Flossie Wong-Staal, Ph.D.

In Memoriam: Flossie Wong-Staal, Ph.D.

Jul 13, 2020

The Center for Cancer Research mourns the recent death of past colleague Flossie Wong-Staal. She was a major figure in the discovery of HIV and the first to clone the virus.  Read more...

Matthew Lindsley

Lieutenant and Research Nurse Matt Lindsley shares his experiences and public service role

Jul 8, 2020

Matthew Lindsley, MPH, MSN, RN PHNA-BC, is a Lieutenant in the United States Public Health Service. As a Research Nurse Specialist for the NCI’s Center for Cancer Research, Neuro-Oncology Branch, Matt helps patients with brain and spine tumors who come to NIH for treatment. He was recently deployed to aid in the COVID-19 response mission in Washington state for a number of weeks.  Read more...

Mary Kearney

Mary Kearney discusses coronavirus with National Geographic

Jul 8, 2020

Mary Kearney, Ph.D., Senior Scientist in the Host-Virus Interaction Branch, was recently quoted in a National Geographic article discussing how long coronavirus lasts inside the body. “Where there’s long-term persistence, there can be long-term consequences,” she says.  Read more...

Gilbert Howlett Smith, Ph.D.

In Memoriam: Gilbert Howlett Smith, Ph.D.

Jul 7, 2020

The Center for Cancer Research mourns the recent death of colleague and friend Gilbert Howlett Smith, Ph.D. He was a valued and much liked member of the NCI community since 1965. Read more...

Isaiah Fidler, D.V.M, Ph.D.

In Memoriam: Isaiah Fidler, D.V.M, Ph.D.

Jun 5, 2020

The Center for Cancer Research mourns the recent death of past colleague and friend Isaiah Fidler, D.V.M., Ph.D. He joined the National Cancer Institute in 1975 and led the metastasis program at the Frederick Cancer Research Facility. His eight years at NCI produced some of his early innovative work in unraveling the riddles of how cancer spreads. Read more...

Stephen Oroszlan

In Memoriam: Stephen Oroszlan, Ph.D.

May 15, 2020

The Center for Cancer Research mourns the recent death of past colleague and friend Stephen Oroszlan. He was an esteemed member of the NCI community from 1976-1995 and served as a Scientist Emeritus since 1995.  Read more...

Eytan Ruppin

Eytan Ruppin quoted in New York Times story on treating COVID-19

May 15, 2020

The New York Times has reported on a new paper detailing drugs with the potential to treat COVID-19 by researchers from international institutions. Eytan Ruppin, Ph.D., Chief of the Cancer Data Science Laboratory, turned the computer network his lab uses toward analyzing some of the drugs that did best in the screening to predict which are likely to succeed in actual patients and in what combinations. Read more...

Ira Pastan

Ira Pastan selected as a 2020 Sammies finalist

May 4, 2020

Ira Pastan, M.D., Co-Chief of the Laboratory of Molecular Biology, has been selected as one of 27 Samuel J. Heyman Service to America Medal (Sammies) finalists. These finalists are outstanding federal employees who serve the public good and are addressing many of our country’s greatest challenges. Dr. Pastan is nominated for discovering a new class of drugs that can successfully treat a rare form of leukemia and hold promise to be effective therapies for pancreatic and lung cancer as well as mesothelioma. Read more...

John Schiller

John Schiller elected to the National Academy of Sciences

Apr 29, 2020

John T. Schiller, Ph.D., Deputy Chief of the Laboratory of Cellular Oncology, has been elected to the National Academy of Sciences for his distinguished and continuing achievements in original research. Dr. Schiller, in close partnership with Dr. Doug Lowy, has made fundamental contributions to our understanding of human papillomavirus (HPV) culminating in the development of the prophylactic vaccines Cervarix and Gardasil, which protect from HPV-related cancers, including cervical cancer. Read more...

Andrea Apolo

Andrea Apolo receives Arthur S. Flemming Award

Apr 21, 2020

Andrea B. Apolo, M.D., NIH Lasker Clinical Research Scholar in the Genitourinary Malignancies Branch, is a recipient of this year’s Arthur S. Flemming Award, which honors the accomplishments of mid-career federal employees. Dr. Apolo received the award for her work leading a clinical trial demonstrating that avelumab treatment led to prolonged survival in patients with refractory metastatic urothelial carcinoma. She then led the effort to get avelumab approved by the FDA for the treatment of bladder cancer. Read more...